首页> 外文OA文献 >Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol The Losartan Intervention For Endpoint Reduction in Hypertension Study

【2h】

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol The Losartan Intervention For Endpoint Reduction in Hypertension Study

机译：随机分为氯沙坦和阿替洛尔治疗高血压患者心脏肥大的卒中减少氯沙坦干预高血压患者终点减少

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Steven M. Snapinn; Katherine E. Harris; Richard B. Devereux; Markku S. Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Kristian Wachtell; Jonathan M; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-pedersen; Lars H. Lindholm; Jorge R. Kizer; Björn Dahlöf; Sverre E. Kjeldsen; Stevo Julius; Gareth Beevers; Ulf De Faire; Jonathan M. Edelman;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. [J] . Kizer JR, Dahlof B, Kjeldsen SE, Hypertension: An Official Journal of the American Heart Association . 2005,第1期

机译：随机分为氯沙坦和阿替洛尔的心脏肥大的高血压成年人的卒中减少：高血压终点研究的氯沙坦干预研究。
2. An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands. [J] . Boersma C, Carides GW, Atthobari J, Clinical therapeutics . 2007,第5期

机译：氯沙坦与阿替洛尔治疗高血压和左心室肥厚的患者的经济评估：适用于荷兰的洛沙坦终点干预干预研究（LIFE）的结果。
3. Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol [J] . Jorge R. Kizer, Bj?rn Dahl?f, Sverre E. Kjeldsen, Hypertension: An Official Journal of the American Heart Association . 2005,第1期

机译：高血压成年人心脏肥大的卒中减少，随机分配给氯沙坦和阿替洛尔
4. Mendelian Randomization of Arsenic Metabolism as a Risk Factor for Hypertensive- and Diabetes-Related Traits among Adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Cohort [C] . Molly Scannell Bryan, Tamar Sofer, Yasmin Mossavar-Rahmani, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：在西班牙裔社区健康研究/拉丁裔（HCHS / SOL）队列研究中，孟德尔随机将砷代谢作为成人高血压和糖尿病相关性状的危险因素
5. Reduction of Angiotensin II Induced Hypertension and Cardiac Fibrosis with GLP-1 Receptor Agonist and DPP-4 Inhibitor via Decreasing NADPH Oxidase Expression [D] . Banks, Trenton Edward. 2020

机译：通过降低NADPH氧化酶表达，通过降低NADPH-1受体激动剂和DPP-4抑制剂减少血管紧张素II诱导的高血压和心肌纤维化
6. PCV52 LOSARTAN-BASED VERSUS ATENOLOL-BASED THERAPY IN PATIENTS WITH HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY: AN ECONOMIC EVALUATION OF THE LOSARTAN INTERVENTION FOR ENDPOINT REDUCTION IN HYPERTENSION (LIFE) STUDY FOR GERMANY [O] . Krobot KJ, Carides GW, Wagner A, 2006

机译：高血压和左心室肥厚患者的PCV52洛沙坦对抗阿替洛尔为基础的治疗：对德国降血压干预干预洛沙坦干预的经济评估，对德国的高血压（生命）研究

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol The Losartan Intervention For Endpoint Reduction in Hypertension Study

著录项

相似文献

相关主题

期刊订阅